Syneos Health Yönetim
Yönetim kriter kontrolleri 1/4
Syneos Health's CEO is Michelle Keefe, appointed in Apr 2022, has a tenure of 1.42 years. total yearly compensation is $8.89M, comprised of 9.7% salary and 90.3% bonuses, including company stock and options. directly owns 0.034% of the company’s shares, worth $1.53M. The average tenure of the management team and the board of directors is 2.7 years and 2.3 years respectively.
Anahtar bilgiler
Michelle Keefe
İcra Kurulu Başkanı
US$8.9m
Toplam tazminat
| CEO maaş yüzdesi | 9.7% |
| CEO görev süresi | 1.4yrs |
| CEO sahipliği | 0.03% |
| Yönetim ortalama görev süresi | 2.7yrs |
| Yönetim Kurulu ortalama görev süresi | 2.3yrs |
Son yönetim güncellemeleri
Recent updates
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 29
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?
Feb 20Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?
Dec 20Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors
Nov 01Syneos, Datavant expand partnership on data analytics for clinical trials
Oct 11Syneos Health falls 13% after update on outlook
Sep 13When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?
Sep 08Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22Syneos Health Q2 2022 Earnings Preview
Aug 01With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case
Jul 19Syneos: Upside Could Be Priced In, Valuations Unsupportive
Jul 15Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?
Jun 18Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Jun 03We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?
Apr 08Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors
Mar 27Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 05Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?
Feb 03With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting
Jan 04Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022
Dec 03Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Dec 03CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | US$71m |
| Mar 31 2023 | n/a | n/a | US$148m |
| Dec 31 2022 | US$9m | US$862k | US$266m |
| Sep 30 2022 | n/a | n/a | US$287m |
| Jun 30 2022 | n/a | n/a | US$278m |
| Mar 31 2022 | n/a | n/a | US$242m |
| Dec 31 2021 | US$2m | US$567k | US$235m |
| Sep 30 2021 | n/a | n/a | US$251m |
| Jun 30 2021 | n/a | n/a | US$236m |
| Mar 31 2021 | n/a | n/a | US$198m |
| Dec 31 2020 | US$2m | US$522k | US$193m |
| Sep 30 2020 | n/a | n/a | US$192m |
| Jun 30 2020 | n/a | n/a | US$187m |
| Mar 31 2020 | n/a | n/a | US$195m |
| Dec 31 2019 | US$2m | US$550k | US$131m |
Tazminat ve Piyasa: Michelle's total compensation ($USD8.89M) is above average for companies of similar size in the US market ($USD6.59M).
Tazminat ve Kazançlar: Michelle's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Michelle Keefe (56 yo)
1.4yrs
Görev süresi
US$8,889,996
Tazminat
Ms. Michelle Keefe serves as Chief Executive Officer at Syneos Health, Inc since April 29, 2022 and serves as its Director since 2022. She served as President of Medical Affairs and Commercial Solutions fo...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Director | 1.4yrs | US$8.89m | 0.034% $ 1.5m | |
| Chief Operating Officer | 1.4yrs | US$6.04m | 0.018% $ 810.0k | |
| General Counsel & Corporate Secretary | 4.8yrs | US$3.52m | 0.014% $ 617.4k | |
| Chief Business Officer | 5yrs | US$2.62m | 0.011% $ 502.0k | |
| Consultant | less than a year | US$3.19m | 0.039% $ 1.8m | |
| Chief Financial Officer | less than a year | Veri yok | Veri yok | |
| Senior VP of Finance & Chief Accounting Officer | 2.7yrs | Veri yok | 0.0029% $ 130.6k | |
| President of Technology & Data Solutions | 1.4yrs | Veri yok | Veri yok | |
| Chief Scientific Officer | 7.5yrs | Veri yok | Veri yok | |
| Chief Information & Digital Officer | 2.8yrs | Veri yok | Veri yok | |
| Senior Vice President of Investor Relations | no data | Veri yok | Veri yok | |
| Global Head of Corporate Communications & Marketing | 6.1yrs | Veri yok | Veri yok |
2.7yrs
Ortalama Görev Süresi
52.5yo
Ortalama Yaş
Deneyimli Yönetim: SYNH's management team is considered experienced (2.7 years average tenure).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Director | 1.7yrs | US$8.89m | 0.034% $ 1.5m | |
| Independent Director | 6.9yrs | US$370.77k | 0.019% $ 865.7k | |
| Independent Director | less than a year | US$182.56k | 0% $ 0 | |
| Independent Director | 6.9yrs | US$322.77k | 0.019% $ 850.1k | |
| Independent Director | 1.7yrs | US$351.39k | 0.0034% $ 150.2k | |
| Independent Chairman | 4.8yrs | US$483.27k | 0.022% $ 972.7k | |
| Independent Director | 2.3yrs | US$308.52k | 0.0048% $ 213.5k | |
| Independent Director | 3.8yrs | US$307.77k | 0.0096% $ 426.2k | |
| Independent Director | 1.7yrs | US$369.53k | 0.0034% $ 151.6k |
2.3yrs
Ortalama Görev Süresi
60yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: SYNH's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.